Stock Events

Stock Events

Sinovac Biotech 

$0.083412
68
+$0.00+0% 15:02 Today

Statistics

Day High
6.47
Day Low
6.47
52W High
6.47
52W Low
0.083412
Volume
0
Avg. Volume
0
Mkt Cap
5.99M
P/E Ratio
6.66
Dividend Yield
5,100.46%
Dividend
4.25

Dividends

5,100.46%Dividend Yield
Jul 25
$55.00
Jul 25
$55.00
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

21AprExpected
Q2 2020
Q3 2020
Q1 2021
Q1 2021
Q2 2021
Q3 2021
Q1 2022
-0.07
0.29
0.64
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-16.63%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
130.27MRevenue
-21.67MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SVA. It's not an investment recommendation.
Microsoft
5
MSFT
Amazon
5
AMZN
Apple
4
AAPL
Tesla
4
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novavax
NVAX
Mkt Cap1.53B
Novavax is a direct competitor in the development and commercialization of vaccines for infectious diseases, similar to Sinovac's core business.
Moderna
MRNA
Mkt Cap55.09B
Moderna is a leader in mRNA technology for vaccines, competing in the same space as Sinovac with its COVID-19 vaccine and other infectious disease vaccines.
BioNTech
BNTX
Mkt Cap25.64B
BioNTech, in partnership with Pfizer, developed a leading mRNA COVID-19 vaccine, directly competing with Sinovac's CoronaVac.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca developed a viral vector COVID-19 vaccine, competing in the global vaccine market alongside Sinovac.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson developed a single-shot COVID-19 vaccine, offering an alternative to Sinovac's vaccine offerings.
Pfizer
PFE
Mkt Cap159.36B
Pfizer, in collaboration with BioNTech, competes in the vaccine market, including COVID-19 vaccines, directly against Sinovac.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is involved in the development and distribution of vaccines, including COVID-19 vaccines, competing with Sinovac's portfolio.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline is a large vaccine manufacturer that competes across various vaccine markets, including COVID-19, with Sinovac.

About

Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of vaccines for the prevention of human infectious diseases, including certain diseases with unmet medical needs. It has developed a comprehensive vaccine portfolio covering hepatitis A, hepatitis B, hand, foot and mouth disease ("HFMD") caused by enterovirus 71 ("EV71"), seasonal and pandemic influenza, COVID-19, pneumococcal disease, poliomyelitis, mumps, varicella, rabies and tetanus. The Company operates exclusively in the research, development, manufacture, and commercialization of vaccines sector. The Company's business is considered as operating in one segment. It has presence in Chinese Mainland, and Outside Chinese Mainland.
Show more...
CEO
Wei Dong Yin
Employees
2602
Country
Other
ISIN
AGP8696W1045
WKN
000789125

Listings

XNAS
US
SVA
MU
DE
SVQ.MU
F
DE
SVQ.F

0 Comments

Share your thoughts

FAQ

What is Sinovac Biotech stock price today?▼
The current price of SVA is $0.08 USD — it has increased by +0% in the past 24 hours. Watch Sinovac Biotech stock price performance more closely on the chart.
What is Sinovac Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Sinovac Biotech stocks are traded under the ticker SVA.
What is Sinovac Biotech market cap?▼
Today Sinovac Biotech has the market capitalization of 5.99M
What is Sinovac Biotech revenue for the last year?▼
Sinovac Biotech revenue for the last year amounts to 130.27M USD.
What is Sinovac Biotech net income for the last year?▼
SVA net income for the last year is -21.67M USD.
Does Sinovac Biotech pay dividends?▼
Yes, SVA dividends are paid en. The last dividend per share was 55 USD. As of today, Dividend Yield (FWD)% is 5,100.46%.
How many employees does Sinovac Biotech have?▼
As of September 04, 2026, the company has 2,602 employees.
In which sector is Sinovac Biotech located?▼
Sinovac Biotech operates in the Health & Wellness sector.
When did Sinovac Biotech complete a stock split?▼
Sinovac Biotech has not had any recent stock splits.
Where is Sinovac Biotech headquartered?▼
Sinovac Biotech is headquartered in Beijing, Other.